Skip to main content
Skip to main content
CVSA logo

Covista Inc. (CVSA)

$130.15 +$0.27 (+0.20%) |Exceptional · 91
Signals are mixed — the Council read leans BUY (65/100) while the AI fundamental score is 91/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Seth Klarman bullish.
MCap: $4.43B| P/E Ratio: 17.7| Vol: 258.7K| Target: $140.00 (+7.6%)| 52-wk range: $86.97 – $156.26
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Covista Inc. (CVSA) trades at $130.15 with AI Score 91/100 (Grade A+). Covista Inc. is a leading provider of post-secondary education, operating through Chamberlain, Walden, and Medical and Veterinary segments. Market cap: $4.43B, Sector: Consumer cyclical.

Price live · AI analysis from Mar 16, 2026
Covista Inc. is a leading provider of post-secondary education, operating through Chamberlain, Walden, and Medical and Veterinary segments. The company focuses on nursing, health professions, and various online degree programs.

CVSA stock analysis for 2026: Analysts have set a consensus price target of $140.00 for Covista Inc., suggesting 7.6% upside from the current price of $130.15. The AI MoonshotScore is 91/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 65/100 · B+

CVSA: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

Covista Inc. (CVSA) Consumer Business Overview

CEOStephen W. Beard
Employees10371
HeadquartersChicago, US
IPO Year2026

Covista Inc., formerly Adtalem Global Education, is a consumer cyclical company providing post-secondary education through its Chamberlain, Walden, and Medical and Veterinary segments. With a market capitalization of $4.43B and a P/E ratio of 17.7, Covista focuses on delivering degree and non-degree programs in nursing, health professions, and online education.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

What Is the Investment Thesis for CVSA?

Covista Inc. presents a compelling investment case based on its strong market position in the post-secondary education sector and its focus on high-demand fields such as nursing and healthcare. With a market capitalization of $4.43B and a profit margin of 13.4%, the company demonstrates financial stability. Key value drivers include the increasing demand for skilled healthcare professionals and the growing adoption of online education. The company's beta of 0.73 suggests lower volatility compared to the broader market. Growth catalysts include expanding program offerings and strategic partnerships. Potential risks include regulatory changes in the education sector and increased competition from other online education providers. Investors should monitor Covista's ability to maintain its gross margin of 57.4% and adapt to evolving student needs.

Based on FMP financials and quantitative analysis

CVSA Key Highlights

  • Market capitalization of $4.43B, reflecting substantial investor confidence in Covista's market position.
  • P/E ratio of 17.7, indicating a reasonable valuation relative to earnings.
  • Profit margin of 13.4%, demonstrating efficient operations and profitability.
  • Gross margin of 57.4%, highlighting the company's ability to maintain pricing power and manage costs effectively.
  • Beta of 0.73, suggesting lower volatility compared to the overall market, making it a potentially stable investment.

Who Are CVSA's Competitors?

CVSA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
LRN Stride, Inc. $90.27 -0.19% $3.84B 96
CECO CECO Environmental Corp. $80.68 -1.79% $2.89B 56
STRA Strategic Education, Inc. $82.42 +1.78% $1.87B 84
ROVR Rover Group, Inc. $10.99 +0.05% $2.00B 62
CVSGF CVS Group plc $16.55 +0.00% $1.15B 52
MCW Mister Car Wash, Inc. $7.10 +0.00% $2.34B 51
RGS Regis Corporation $27.50 +1.49% $68.73M 51
MED Medifast, Inc. $10.96 -0.63% $121.87M 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CVSA's Key Strengths?

  • Strong brand reputation in nursing and healthcare education.
  • Extensive network of healthcare partners.
  • Focus on high-demand fields.
  • Established online education platform.

What Are CVSA's Weaknesses?

  • Dependence on regulatory approvals and accreditation.
  • Exposure to economic cycles and student enrollment trends.
  • Competition from other online education providers.
  • Potential for negative publicity related to student outcomes.

What Could Drive CVSA Stock Higher?

  • Launch of new online programs in emerging fields such as data science and artificial intelligence (Q4 2026).
  • Strategic partnerships with leading healthcare institutions to provide clinical experience and job placement opportunities.
  • Investment in innovative learning technologies to enhance the student experience.
  • Geographic expansion into emerging markets with a growing demand for higher education (2027).

What Are the Key Risks for CVSA?

  • Insider selling — insiders were net sellers of roughly $1.9M recently.
  • Changes in government regulations and funding policies could impact Covista's revenue and profitability.
  • Increased competition from other online education providers could lead to pricing pressures and reduced market share.
  • Economic downturns could affect student enrollment and tuition revenue.
  • Cybersecurity threats and data breaches could damage Covista's reputation and result in financial losses.
  • Negative publicity related to student outcomes or program quality could impact enrollment and brand image.

What Are the Growth Opportunities for CVSA?

  • Expansion of Online Program Offerings: Covista has the opportunity to expand its online program offerings to cater to a broader range of students and professionals. The global online education market is projected to reach $325 billion by 2025, presenting a significant growth opportunity. By introducing new programs in emerging fields such as data science, artificial intelligence, and cybersecurity, Covista can attract a new segment of students and increase its market share. This expansion can be achieved through strategic partnerships with industry leaders and investments in innovative learning technologies. Timeline: 2026-2028.
  • Strategic Partnerships with Healthcare Institutions: Covista can strengthen its position in the healthcare education market by forming strategic partnerships with leading healthcare institutions. These partnerships can provide students with valuable clinical experience and job placement opportunities. The demand for healthcare professionals is expected to grow significantly in the coming years, driven by an aging population and advancements in medical technology. By collaborating with hospitals, clinics, and other healthcare providers, Covista can ensure that its graduates are well-prepared to meet the evolving needs of the healthcare industry. Timeline: Ongoing.
  • Geographic Expansion into Emerging Markets: Covista can explore opportunities for geographic expansion into emerging markets with a growing demand for higher education. Countries in Asia, Africa, and Latin America are experiencing rapid economic growth and a rising middle class, leading to increased demand for quality education. By establishing a presence in these markets, Covista can tap into a new pool of students and diversify its revenue streams. This expansion can be achieved through partnerships with local institutions and the development of culturally relevant programs. Timeline: 2027-2030.
  • Investment in Innovative Learning Technologies: Covista can enhance its educational offerings by investing in innovative learning technologies such as artificial intelligence, virtual reality, and augmented reality. These technologies can provide students with personalized learning experiences and improve learning outcomes. The market for educational technology is projected to reach $404 billion by 2026, presenting a significant opportunity for Covista to differentiate itself from its competitors. By integrating these technologies into its programs, Covista can attract tech-savvy students and enhance its reputation as a leader in educational innovation. Timeline: Ongoing.
  • Development of Stackable Credentials and Micro-credentials: Covista can cater to the needs of working professionals by developing stackable credentials and micro-credentials that provide targeted skills and knowledge. These credentials can be earned in a shorter amount of time and can be stacked together to form a degree or certificate. The demand for micro-credentials is growing rapidly, as employers increasingly value specific skills and competencies. By offering these credentials, Covista can attract a new segment of students who are looking to upskill or reskill quickly. This can be achieved through partnerships with industry experts and the development of competency-based assessments. Timeline: 2026-2028.

What Opportunities Does CVSA Have?

  • Expansion of online program offerings.
  • Strategic partnerships with healthcare institutions.
  • Geographic expansion into emerging markets.
  • Investment in innovative learning technologies.

What Threats Does CVSA Face?

  • Changes in government regulations and funding policies.
  • Increased competition from other education providers.
  • Economic downturns affecting student enrollment.
  • Cybersecurity threats and data breaches.

What Are CVSA's Competitive Advantages?

  • Strong brand reputation in the nursing and healthcare education market.
  • Extensive network of healthcare partners providing clinical experience and job opportunities.
  • Focus on high-demand fields with strong career prospects for graduates.

What Does CVSA Do?

Covista Inc., formerly known as Adtalem Global Education, was founded in 1973 by Dennis J. Keller and Ronald L. Taylor. Headquartered in Chicago, Illinois, the company has evolved into a prominent provider of post-secondary education. Covista operates through three main segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in nursing and health professions. The Walden segment provides online certificates, bachelor's, master's, and doctoral degrees in fields such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary segment focuses on degree and non-degree programs in the medical and veterinary postsecondary education industry. Covista's mission is to empower students and professionals to achieve their educational and career goals through accessible and innovative learning experiences. With a workforce of 10,371 employees, Covista continues to expand its reach and impact in the education sector.

What Products and Services Does CVSA Offer?

  • Provides post-secondary education in nursing and health professions through the Chamberlain segment.
  • Offers online certificates, bachelor's, master's, and doctoral degrees through the Walden segment.
  • Delivers degree and non-degree programs in the medical and veterinary fields through the Medical and Veterinary segment.
  • Focuses on high-demand fields such as nursing, healthcare, and education.
  • Offers flexible learning options through online and hybrid programs.
  • Partners with healthcare institutions to provide clinical experience and job placement opportunities.

How Does CVSA Make Money?

  • Generates revenue through tuition fees from students enrolled in its various programs.
  • Offers a range of degree and non-degree programs to cater to different student needs.
  • Focuses on high-demand fields to ensure strong enrollment and career outcomes for graduates.

What Industry Does CVSA Operate In?

Covista Inc. operates in the consumer cyclical sector, specifically within the personal products and services industry, which includes post-secondary education. The market for online education is experiencing significant growth, driven by increasing demand for flexible learning options and the rising cost of traditional education. The competitive landscape includes both traditional universities and other for-profit education providers. Covista's focus on high-demand fields like nursing and healthcare positions it favorably within this market. The company's ability to adapt to changing student needs and technological advancements will be crucial for maintaining its competitive edge.

Who Are CVSA's Key Customers?

  • Students seeking degrees and certificates in nursing and health professions.
  • Working professionals looking to advance their careers through online education.
  • Healthcare institutions seeking qualified graduates to fill critical roles.
AI Confidence: 71% Updated: Mar 16, 2026

ROE 17%Key Financial Metrics

Return on equity for Covista Inc. stands at 16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.6%, showing how much profit it generates from its asset base. CVSA trades at a trailing price-to-earnings ratio of 17.68, below the Consumer Cyclical sector average of ~39x. Its free cash flow yield is 7.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.70 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 5.5%, the inverse of the P/E and a quick read on earnings relative to price.

Covista Inc. (CVSA) Valuation Context

Valued at $4.43B, CVSA is classified as a mid-cap stock. Relative to its peer group, CVSA's quantitative score of 91/100 is above the peer average of 70/100.

Company Profile

Covista Inc. operates in the Personal Products & Services industry within the Consumer Cyclical sector. It is headquartered in Chicago, US. The company is led by CEO Stephen W. Beard. CVSA has traded publicly since 2026.

F-Score 7/9Financial Health

Covista Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.51 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Covista Inc. revenue of about $1.94B for fiscal 2026, with EPS near $8.05. The estimate reflects 3 contributing analysts.

Net sellingInsider Activity

Over the past six months, Covista Inc. insiders filed 12 SEC Form 4 transactions — 8 sales and 4 purchases. On net that is roughly 6K shares disposed (about $1.9M), a signal worth weighing alongside the fundamentals.

CVSA Financials

Fundamental Snapshot

Revenue Growth (FY)
+12.9%
Net Income Growth (FY)
+70.1%
EPS Growth (FY)
+79.7%
Free Cash Flow Growth (FY)
+16.5%
P/E (TTM)
18.3
Return on Equity (TTM)
+16.6%
Current Ratio
0.7
EV/EBITDA (TTM)
11.2

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Covista's future prospects, indicating that executives believe the company is undervalued.
  • Community sentiment has shifted positively, with discussions highlighting Covista's innovative solutions and strong market position.
  • Analysts are noting an increase in demand for Covista's services, which could lead to significant revenue growth in the near term.
  • The company's recent partnerships have been well-received, enhancing its credibility and expanding its market reach.

Bear Case

  • Some analysts express concerns about the competitive landscape, suggesting that Covista may struggle to maintain its market share.
  • Recent social sentiment shows a divide, with some community members questioning the sustainability of Covista's growth strategy.
  • There are lingering doubts about the company's ability to scale operations efficiently, which could impact profitability.
  • Market perception is mixed, with some investors wary of potential regulatory challenges that could affect Covista's operations.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

CVSA Latest News

CVSA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CVSA.

Price Targets

Consensus target: $140.00

CVSA MoonshotScore

91/100

What does this score mean?

The MoonshotScore rates CVSA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Covista Inc. Analysis

Leadership: Stephen W. Beard

CEO

Stephen W. Beard serves as the CEO of Covista Inc., leading a workforce of 10,371 employees. His career spans various leadership roles in the education and healthcare sectors. He has a strong background in strategic planning, operational management, and business development. Beard is known for his focus on innovation and student success. His experience includes driving growth initiatives and fostering a culture of excellence within organizations. He holds advanced degrees in business administration and education.

Track Record: Under Stephen W. Beard's leadership, Covista Inc. has focused on expanding its online program offerings and strengthening its partnerships with healthcare institutions. Key milestones include the launch of new programs in high-demand fields and the implementation of innovative learning technologies. Beard has also overseen efforts to improve student outcomes and enhance the overall student experience. His strategic decisions have contributed to the company's growth and market position.

Covista Inc. Consumer Cyclical Stock: Key Questions Answered

What does Covista Inc. do?

Covista Inc. is a leading provider of post-secondary education, operating through its Chamberlain, Walden, and Medical and Veterinary segments. The company offers a range of degree and non-degree programs in fields such as nursing, healthcare, education, and business. Covista focuses on providing flexible learning options through online and hybrid programs, catering to the needs of students and working professionals. The company's mission is to empower students to achieve their educational and career goals through accessible and innovative learning experiences. Covista also partners with healthcare institutions to provide clinical experience and job placement opportunities for its graduates.

What are the main risks for CVSA?

Covista Inc. faces several risks inherent to the consumer cyclical and education sectors. Changes in government regulations and funding policies could significantly impact the company's revenue and profitability. Increased competition from other online education providers could lead to pricing pressures and reduced market share. Economic downturns could affect student enrollment and tuition revenue. Cybersecurity threats and data breaches pose a risk to Covista's reputation and financial stability. Negative publicity related to student outcomes or program quality could also impact enrollment and brand image. Investors should carefully consider these risks before investing in CVSA.

What are the key factors to evaluate for CVSA?

Covista Inc. (CVSA) holds an AI score of 91/100 (high). P/E: 17.7x vs the S&P 500's ~20-25x. Analysts target $140.00 (+8%). Not financial advice.

How frequently does CVSA data refresh on this page?

CVSA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CVSA's recent stock price performance?

Covista Inc. (CVSA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation in nursing and healthcare education. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CVSA overvalued or undervalued right now?

Covista Inc. (CVSA) trades at 17.7x earnings. Analysts target $140.00 (+8%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying CVSA?

Before investing in Covista Inc. (CVSA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CVSA to a portfolio?

Key strength of Covista Inc. (CVSA): Strong brand reputation in nursing and healthcare education. Its MoonshotScore of 91/100 reflects strong quantitative fundamentals. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data and market projections are based on available information and industry reports.
  • AI analysis is pending and may provide additional insights in the future.
Data Sources

Popular Stocks